Skip to main content
Top
Published in: Infection 4/2012

01-08-2012 | Clinical and Epidemiological Study

Tuberculosis among drug users and homeless persons: impact of voluntary X-ray investigation on active case finding

Authors: U. Goetsch, O. K. Bellinger, K.-L. Buettel, R. Gottschalk

Published in: Infection | Issue 4/2012

Login to get access

Abstract

Background

Illicit drug use and homelessness are major contributors to the incidence of tuberculosis (TB) among inhabitants of major cities.

Objective

The primary objective of this study was to establish a sustainable low-threshold chest X-ray screening programme for pulmonary TB among illicit drug users and homeless persons and to integrate this into the existing public health programme for active case finding. A secondary objective was to estimate the coverage of the programme, assess other risk factors and determine TB rates and treatment outcome in these two groups.

Methods

Illicit drug users and homeless persons were asked to voluntarily participate in an X-ray screening programme. The coverage of the intervention, total number and characteristics of cases and the follow-up of treatment were assessed.

Results

A total of 4,529 chest radiographs were made from 3,477 persons, of whom 66% were homeless and 34% were illicit drug users, between May 2002 and April 2007. Coverage for screening once every 2 years ranged between 18 and 26%. Thirty-nine TB cases (14 drug users, 25 homeless persons) were identified, representing 8.7% of the total case load of 448 notified cases of pulmonary TB in Frankfurt during this period. Among the drug users, human immunodeficiency virus coinfection (10/14) seemed to play a key role in the development of TB. The case-finding rate of 861/100,000 radiographs (1,122/100,000 persons) is as high as that in routine contact investigations (1,078/100,000). Among all individuals with TB, 76% completed treatment.

Conclusion

A novel targeted TB screening approach with voluntary radiographic examination of illicit drug users and homeless persons can be integrated into the existing public TB prevention programme and provides a high case-finding rate.
Literature
1.
go back to reference Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis. 2003;7(8):751–7.PubMed Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis. 2003;7(8):751–7.PubMed
2.
go back to reference Moore-Gillon J. Tuberculosis and poverty in the developed world. PD D: Chapman and Hall; 1998. Moore-Gillon J. Tuberculosis and poverty in the developed world. PD D: Chapman and Hall; 1998.
3.
go back to reference Hopewell PC. Targeting tuberculosis prevention. Am J Respir Crit Care Med. 2000;162(6):2017–8.PubMed Hopewell PC. Targeting tuberculosis prevention. Am J Respir Crit Care Med. 2000;162(6):2017–8.PubMed
4.
go back to reference Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med. 2008;177(3):348–55. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, et al. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med. 2008;177(3):348–55.
5.
go back to reference Moonan PK, Weis SE. Assessing the impact of targeted tuberculosis interventions. Am J Respir Crit Care Med. 2008;177(5):557–8. Moonan PK, Weis SE. Assessing the impact of targeted tuberculosis interventions. Am J Respir Crit Care Med. 2008;177(5):557–8.
6.
go back to reference Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62(8):667–71.PubMedCrossRef Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax. 2007;62(8):667–71.PubMedCrossRef
7.
go back to reference Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994–2003. JAMA. 2005;293(22):2762–6. Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994–2003. JAMA. 2005;293(22):2762–6.
8.
go back to reference Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102(2):164–70.PubMedCrossRef Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102(2):164–70.PubMedCrossRef
9.
go back to reference Diel R, Schneider S, Meywald-Walter K, Ruf CM, Rusch-Gerdes S, Niemann S. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol. 2002;40(2):532–9.PubMedCrossRef Diel R, Schneider S, Meywald-Walter K, Ruf CM, Rusch-Gerdes S, Niemann S. Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol. 2002;40(2):532–9.PubMedCrossRef
10.
go back to reference Conover C, Ridzon R, Valway S, Schoenstadt L, McAuley J, Onorato I, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis. 2001;5(1):59–64.PubMed Conover C, Ridzon R, Valway S, Schoenstadt L, McAuley J, Onorato I, et al. Outbreak of multidrug-resistant tuberculosis at a methadone treatment program. Int J Tuberc Lung Dis. 2001;5(1):59–64.PubMed
11.
go back to reference Curtis AB, Ridzon R, Novick LF, Driscoll J, Blair D, Oxtoby M, et al. Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis. 2000;4(4):308–13.PubMed Curtis AB, Ridzon R, Novick LF, Driscoll J, Blair D, Oxtoby M, et al. Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak. Int J Tuberc Lung Dis. 2000;4(4):308–13.PubMed
12.
go back to reference Story A, van Hest R, Hayward A. Tuberculosis and social exclusion. Br Med J. 2006;333(7558):57–8. Story A, van Hest R, Hayward A. Tuberculosis and social exclusion. Br Med J. 2006;333(7558):57–8.
13.
go back to reference Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002;287(8):991–5. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002;287(8):991–5.
14.
go back to reference de Vries G, van Hest RA. From contact investigation to tuberculosis screening of drug addicts and homeless persons in Rotterdam. Eur J Public Health. 2006;16(2):133–6.PubMedCrossRef de Vries G, van Hest RA. From contact investigation to tuberculosis screening of drug addicts and homeless persons in Rotterdam. Eur J Public Health. 2006;16(2):133–6.PubMedCrossRef
15.
go back to reference Li J, Driver CR, Munsiff SS, Fujiwara PI. Finding contacts of homeless tuberculosis patients in New York City. Int J Tuberc Lung Dis. 2003;7[12 Suppl 3]:S397–404. Li J, Driver CR, Munsiff SS, Fujiwara PI. Finding contacts of homeless tuberculosis patients in New York City. Int J Tuberc Lung Dis. 2003;7[12 Suppl 3]:S397–404.
16.
go back to reference Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000;160(5):697–702. Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, et al. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Arch Intern Med. 2000;160(5):697–702.
17.
go back to reference Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111(5):1168–73. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111(5):1168–73.
18.
go back to reference Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8(11):1280–4.PubMedCrossRef Kong PM, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, et al. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis. 2002;8(11):1280–4.PubMedCrossRef
19.
go back to reference Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Am J Respir Crit Care Med. 1998;157(1):19–22.PubMed Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF. Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Am J Respir Crit Care Med. 1998;157(1):19–22.PubMed
20.
go back to reference Southern A, Premaratne N, English M, Balazs J, O’Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3(11):1001–8.PubMed Southern A, Premaratne N, English M, Balazs J, O’Sullivan D. Tuberculosis among homeless people in London: an effective model of screening and treatment. Int J Tuberc Lung Dis. 1999;3(11):1001–8.PubMed
21.
go back to reference Keizer ST, Langendam MM, van Deutekom H, Coutinho RA, van Ameijden EJ. How does tuberculosis relate to HIV positive and HIV negative drug users? J Epidemiol Community Health. 2000;54(1):64–8.PubMedCrossRef Keizer ST, Langendam MM, van Deutekom H, Coutinho RA, van Ameijden EJ. How does tuberculosis relate to HIV positive and HIV negative drug users? J Epidemiol Community Health. 2000;54(1):64–8.PubMedCrossRef
22.
go back to reference Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765–75. Broekmans JF, Migliori GB, Rieder HL, Lees J, Ruutu P, Loddenkemper R, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J. 2002;19(4):765–75.
23.
go back to reference Bales S, Baumann HG, Schnitzler N. Infektionsschutzgesetz. 2 edn. Stuttgart: W. Kohlhammer GmbH; 2003. Bales S, Baumann HG, Schnitzler N. Infektionsschutzgesetz. 2 edn. Stuttgart: W. Kohlhammer GmbH; 2003.
24.
go back to reference Diel R, Forssbohm M, Loytved G, Haas W, Hauer B, Maffei D, et al. Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis. Gesundheitswesen. 2007;69(8–9):488–503. Diel R, Forssbohm M, Loytved G, Haas W, Hauer B, Maffei D, et al. Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis. Gesundheitswesen. 2007;69(8–9):488–503.
25.
go back to reference Chao A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics. 1987;43(4):783–91.PubMedCrossRef Chao A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics. 1987;43(4):783–91.PubMedCrossRef
26.
go back to reference Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med. 1999;17(2):108–13.PubMedCrossRef Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med. 1999;17(2):108–13.PubMedCrossRef
27.
go back to reference Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med. 1996;156(2):161–5. Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med. 1996;156(2):161–5.
28.
go back to reference Solsona J, Cayla JA, Nadal J, Bedia M, Mata C, Brau J, et al. Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol. 2001;17(2):123–8.PubMedCrossRef Solsona J, Cayla JA, Nadal J, Bedia M, Mata C, Brau J, et al. Screening for tuberculosis upon admission to shelters and free-meal services. Eur J Epidemiol. 2001;17(2):123–8.PubMedCrossRef
29.
go back to reference Snyder DC, Paz EA, Mohle-Boetani JC, Fallstad R, Black RL, Chin DP. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Am J Respir Crit Care Med. 1999;160(1):178–85. Snyder DC, Paz EA, Mohle-Boetani JC, Fallstad R, Black RL, Chin DP. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Am J Respir Crit Care Med. 1999;160(1):178–85.
30.
go back to reference Van Hest NA, De Vries G, Smit F, Grant AD, Richardus JH. Estimating the coverage of a targeted mobile tuberculosis screening programme among illicit drug users and homeless persons with truncated models. Epidemiol Infect. 2008;136(5):628–35.PubMed Van Hest NA, De Vries G, Smit F, Grant AD, Richardus JH. Estimating the coverage of a targeted mobile tuberculosis screening programme among illicit drug users and homeless persons with truncated models. Epidemiol Infect. 2008;136(5):628–35.PubMed
31.
go back to reference van Asten L, Langendam M, Zangerle R, Hernandez Aguado I, Boufassa F, Schiffer V, et al. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion. Aids. 2003;17(8):1201–8. van Asten L, Langendam M, Zangerle R, Hernandez Aguado I, Boufassa F, Schiffer V, et al. Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion. Aids. 2003;17(8):1201–8.
32.
go back to reference Cayla JA, Garcia de Olalla P, Galdos-Tanguis H, Vidal R, Lopez-Colomes JL, Gatell JM, et al. The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. Aids. 1996;10(12):1446–7.PubMedCrossRef Cayla JA, Garcia de Olalla P, Galdos-Tanguis H, Vidal R, Lopez-Colomes JL, Gatell JM, et al. The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. Aids. 1996;10(12):1446–7.PubMedCrossRef
33.
go back to reference Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000;162(2 Pt 1):460–4. Moss AR, Hahn JA, Tulsky JP, Daley CL, Small PM, Hopewell PC. Tuberculosis in the homeless. A prospective study. Am J Respir Crit Care Med. 2000;162(2 Pt 1):460–4.
34.
go back to reference Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139(3):337–9.PubMedCrossRef Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139(3):337–9.PubMedCrossRef
35.
go back to reference Frankfurt Co. Statistisches Jahrbuch. Amt für Statistik: Frankfurt; 2007. Frankfurt Co. Statistisches Jahrbuch. Amt für Statistik: Frankfurt; 2007.
36.
go back to reference Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001;110(8):610–5. Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, et al. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001;110(8):610–5.
Metadata
Title
Tuberculosis among drug users and homeless persons: impact of voluntary X-ray investigation on active case finding
Authors
U. Goetsch
O. K. Bellinger
K.-L. Buettel
R. Gottschalk
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Infection / Issue 4/2012
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0238-x

Other articles of this Issue 4/2012

Infection 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.